EVENTS | VIEW CALENDAR
Leica Biosystems acquires Kreatech Diagnostics
WETZLAR, Germany—Early July brought the news that Leica Biosystems had acquired Amsterdam, The Netherlands-based Kreatech Diagnostics, a privately held provider of DNA fluorescent in-situ hybridization (FISH) probes and target labeling reagents for microarrays.
Kreatech will join Leica Biosystems' Advanced Staining business unit based in Newcastle-upon-Tyne in the United Kingdom, and the combined business will develop targeted biomarker menus for Leica's instrument platforms. Leica Biosystems provides the ThermoBrite and BOND systems that are widely used to label tissue specimens for diagnostic interpretation in cytogenetics and pathology laboratories globally.
Expressing pleasure at the acquisition and predicting the addition of the company will help Leica Biosystems to better serve its cytogenetics and anatomic pathology customers, company president Dr. Matthias G. Weber also makes note of Kreatech's "extensive portfolio and development expertise" that will "enable us to actively support the future development of personalized medicine by research and drug development companies."
"By standardizing and supporting the interpretation of results with our Aperio ePathology imaging solutions," he adds, "we will provide our customers with the ability to effectively and efficiently manage ever more complex diagnostic requirements."
Kreatech's CEO, Kees Moonen, describes Leica Biosystems as "a very natural fit to take Kreatech to the next stage," adding that "Leica will bring global brand recognition, worldwide commercial reach, extensive cytogenetics and histology portfolios and the automation of diagnostic tests on well-established systems. This will tremendously increase the number of customers that can benefit from Kreatech's superior solutions."
The acquisition of Kreatech Diagnostics marks the second one for Leica in July. The other was outside of Europe, in Brazil, and was announced the same day as the Kreatech acquisition. In that deal, Leica Biosystems and Leica Microsystems acquired all shares of Aotec Instrumentos Cientificos Ltd. of São Paulo, Brazil, in a move Leica said "cemented ties" with the Brazilian Leica distributor.
Aotec is a provider of microscopy and histopathology solutions and has been a Leica distributor for more than 25 years, and reportedly all Aotec associates will remain with Aotec subsequent to the acquisition. Additionally, the company is actively hiring additional staff to enlarge the Brazilian teams, and thus Leica Microsystems and Leica Biosystems say they have strengthened their market position significantly.
"Brazil is a very important market. Through this acquisition, we are developing our business further and invest into the service to our customers," said Dr. Jürgen Kress, senior sales director for high-growth markets at Leica Biosystems.
The current management teams will work on the integration of the businesses and operate from the existing headquarters in Sao Paulo.